Disclaimer

The U.S. section of Abbottep.com is a product-specific website that is NOT intended for non U.S. residents. This web content is exclusively reserved for health care professionals in the United States.

Do you wish to continue to visit the Abbottep.com U.S. section?

Get your rhythm back.

Serious heart rhythm disorders called arrhythmias, affect the lives of millions of people daily. Unfortunately, most treatments for these conditions are generic and one-size-fits-all, with mixed results.


But there’s hope.


We believe there is a better way to treat serious heart rhythm disorders such as atrial fibrillation and ventricular tachycardia. Using Abbott Electrophysiology’s technology, doctors can identify the sources of arrhythmias that are unique to each person. Now treatment can be tailored to your individual needs.


Find Your Source.
Get Tailored Therapy.
Get Your Rhythm Back.

Find a doctor near you who is using the Topera Rotor Mapping System

The most common heart rhythm disorder, atrial fibrillation (AF, or afib) is a serious global public health problem which affects millions of people around the world. If left untreated, AF doubles the risk of heart-related deaths and also increases stroke risk by up to 500%. Unfortunately, although it is such a serious health problem, AF has historically been difficult to treat with an acceptable degree of success.

In response to this unaddressed need, Abbott, Inc. has developed a unique 3D analysis and mapping solution (the Abbott 3D Mapping System), which consists of the RhythmView Workstation and FIRMap diagnostic catheter. The Abbott 3D Mapping System has been designed to enable physicians to view the electrical activity of the heart, thereby supporting the diagnosis and patient-specific treatment planning for a variety of heart arrhythmias including atrial fibrillation, atrial flutter, atrial tachycardia, and ventricular tachycardia.

The Abbott 3D Mapping System received FDA clearance in 2013 and is now in routine use at several leading medical centers throughout the United States.

Topera, Inc. Receives Most Innovative New Product Award from CONNECT

mip-2014-winner-seal

MENLO PARK, Calif.–(BUSINESS WIRE)–Topera, Inc. a venture backed medical device company that has developed a suite of products to assist in the identification of sources that sustain complex cardiac arrhythmias, today announced that its RhythmView 3D Mapping System™ received the Most Innovative New Product (MIP) Award at the 2014 CONNECT MIP Awards.

“We are very pleased to be recognized with this award and excited about the ability to bring this first-of-a-kind technology for identifying the patient specific sources of arrhythmias to the millions of people around the world who suffer from heart rhythm disorders”

Topera’s RhythmView 3D Mapping System received San Diego’s most prestigious honor for technology and life sciences innovation in the Pharmaceutical Drugs and Medical Devices category, based on its innovative electrophysiology platform to improve the diagnosis and treatment of complex cardiac arrhythmias including atrial fibrillation, the most common heart rhythm disorder in the world, afflicting 8 million people in the US and Europe alone.

“We are very pleased to be recognized with this award and excited about the ability to bring this first-of-a-kind technology for identifying the patient specific sources of arrhythmias to the millions of people around the world who suffer from heart rhythm disorders,” said co-Founder, Chief Medical Officer and Chief Technology Officer, Ruchir Sehra, MD. “We also want to acknowledge the close partnership we have had with the University of California, San Diego (UCSD) Technology Transfer Office since 2010 that has contributed to Topera being chosen for this prestigious award.”

Topera’s novel 3D analysis and mapping system assists electrophysiologists in the identification of the electrical source of complex cardiac arrhythmias. With the Topera 3D Mapping System patient outcomes can be potentially improved by enabling electrophysiologists to view a dynamic representation of the electrical activity of the heart, supporting the diagnosis of the arrhythmia source and treatment planning for a variety of heart rhythm disorders including atrial fibrillation, atrial flutter, atrial tachycardia, and ventricular tachycardia.

For more information on Topera’s novel RhythmView 3D Mapping System, please visit www.abbottep.com. For a complete list of winners and additional information on the CONNECT MIP Awards, please visit wwww.connect.org.

About Topera

Topera (Topera, Inc.), a venture backed medical device company, has developed a novel 3-D analysis and mapping system to assist electrophysiologists in the identification of the electrical source of complex cardiac arrhythmias. The Topera 3-D Mapping System is designed to improve patient outcomes by enabling electrophysiologists to view a dynamic representation of the electrical activity of the heart, supporting the diagnosis of and treatment planning for a variety of arrhythmias including atrial fibrillation, atrial flutter, atrial tachycardia, and ventricular tachycardia.

About CONNECT

CONNECT is an acceleration program in San Diego that creates and scales great companies in technology and life sciences sectors by creating an environment in which inventors and entrepreneurs have access to the resources they need for success. Since 1985 CONNECT has assisted in the formation and development of more than 3,000 companies and is now widely regarded as one of the world’s most successful organizations linking inventors and entrepreneurs with the resources they need for commercialization of innovative products. As a result, the program has been modeled in more than 50 regions around the world.

Contacts
Topera
Rick Green, 314-422-8158